Malignant hyperthermia — the two words one never wants to hear when administering general anesthesia. But when it does occur, be ready with Dantrium IV, a sterile, non-pyrogenic, lyophilized formulation of dantrolene sodium injection available from Par Pharmaceutical, an endo international company. Since the 1960s, it is Outpatient Surgery Magazine's understanding that Dantrium IV has reduced MH-related fatalities by 70%. The product has 36 months of shelf life, is easy to open, mixes in just 20 seconds, and is priced very competitively.
For more information, call (800) 828-9393, visit www.parsterileproducts.com or click on "Learn More" below.
Your product information request has been received and we will forward information to the contact information you provided shortly.